Michael E Lewis - Net Worth and Insider Trading
Michael E Lewis Net Worth
The estimated net worth of Michael E Lewis is at least $105,962 dollars as of 2024-11-13. Michael E Lewis is the Chief Scientific Advisor of Cara Therapeutics Inc and owns about 314,988 shares of Cara Therapeutics Inc (CARA) stock worth over $105,962. Details can be seen in Michael E Lewis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael E Lewis has not made any transactions after 2016-01-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael E Lewis
Michael E Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael E Lewis owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Aeolus Pharmaceuticals Inc (AOLS) .
Click here to see the complete history of Michael E Lewis’s form 4 insider trades.
Insider Ownership Summary of Michael E Lewis
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CARA | Cara Therapeutics Inc | 2016-01-26 | Chief Scientific Advisor |
AOLS | Aeolus Pharmaceuticals Inc | 2013-05-08 | director |
Michael E Lewis Latest Holdings Summary
Michael E Lewis currently owns a total of 1 stock. Michael E Lewis owns 314,988 shares of Cara Therapeutics Inc (CARA) as of January 26, 2016, with a value of $105,962.
Latest Holdings of Michael E Lewis
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CARA | Cara Therapeutics Inc | 2016-01-26 | 314,988 | 0.34 | 105,962 |
Holding Weightings of Michael E Lewis
Michael E Lewis Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael E Lewis has made a total of 0 transactions in Cara Therapeutics Inc (CARA) over the past 5 years. The most-recent trade in Cara Therapeutics Inc is the sale of 7,262 shares on January 26, 2016, which brought Michael E Lewis around $79,374.
Insider Trading History of Michael E Lewis
- 1
Michael E Lewis Trading Performance
Michael E Lewis Ownership Network
Ownership Network List of Michael E Lewis
Ownership Network Relation of Michael E Lewis
Michael E Lewis Owned Company Details
What does Cara Therapeutics Inc do?
Who are the key executives at Cara Therapeutics Inc?
Michael E Lewis is the Chief Scientific Advisor of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .
Cara Therapeutics Inc (CARA) Insider Trades Summary
Over the past 18 months, Michael E Lewis made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,412 shares made by Christopher Posner , a net sale of 5,476 shares made by Joana Goncalves , and a net sale of 5,236 shares made by Scott Terrillion .
In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 74,117 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,117 shares.
Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cara Therapeutics Inc Insider Transactions
Michael E Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Michael E Lewis. You might contact Michael E Lewis via mailing address: C/o Cara Therapeutics, Inc., 1 Parrott Drive, Shelton Ct 06484.